drugset / Trial / NCT01067430

Comparison of the Effect of Etoricoxib and Diclofenac on Early Morning Activity in Rheumatoid Arthritis (RA)

NCT01067430

RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to explore the effect of Etoricoxib compared to Diclofenac on physical activity in RA subjects with early morning pain and stiffness.

Timeline

Start
2010-04
Primary completion
2010-10
Completion
2011-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Diclofenac Other / unclassified 50 mg
Comparator Etoricoxib Small molecule 90 mg

Indications